title: Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes.
abstract: Criteria, scoring systems, and treatment algorithms for myelodysplastic syndromes (MDS) have been updated repeatedly in recent years. This apparently results from increased awareness and early recognition of the disease, an increasing number of new diagnostic and prognostic markers and tools, and new therapeutic options that may change the course and thus prognosis in MDS. To address these challenges and to create useful new diagnostic and prognostic parameters and scores, the German-Austrian Working Group for Studying Prognostic Factors in MDS was established in 2003 and later was extended to centers in Switzerland (D-A-CH group). In addition, the group cooperates with the European LeukemiaNet, the MDS Foundation, and other national and international working groups in order to improve diagnosis and prognostication. The current article represents a meeting report from the latest workshop organized by the group in Vienna in October 2008.
authors.affiliation: Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria. peter.valent@meduniwien.ac.at
authors.forename: Peter
authors.initials: P
authors.lastname: Valent
authors.forename: Wolf-Karsten
authors.initials: WK
authors.lastname: Hofmann
authors.forename: Guntram
authors.initials: G
authors.lastname: Büsche
authors.forename: Karl
authors.initials: K
authors.lastname: Sotlar
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Horny
authors.forename: Detlef
authors.initials: D
authors.lastname: Haase
authors.forename: Torsten
authors.initials: T
authors.lastname: Haferlach
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Kern
authors.forename: Peter
authors.initials: P
authors.lastname: Bettelheim
authors.forename: Christian
authors.initials: C
authors.lastname: Baumgartner
authors.forename: Wolfgang R
authors.initials: WR
authors.lastname: Sperr
authors.forename: Thomas
authors.initials: T
authors.lastname: Nösslinger
authors.forename: Friedrich
authors.initials: F
authors.lastname: Wimazal
authors.forename: Aristoteles A
authors.initials: AA
authors.lastname: Giagounidis
authors.forename: Michael
authors.initials: M
authors.lastname: Lübbert
authors.forename: Otto
authors.initials: O
authors.lastname: Krieger
authors.forename: Hans-Jochem
authors.initials: HJ
authors.lastname: Kolb
authors.forename: Reinhard
authors.initials: R
authors.lastname: Stauder
authors.forename: Michael
authors.initials: M
authors.lastname: Pfeilstöcker
authors.forename: Norbert
authors.initials: N
authors.lastname: Gattermann
authors.forename: Christa
authors.initials: C
authors.lastname: Fonatsch
authors.forename: Carlo
authors.initials: C
authors.lastname: Aul
authors.forename: Ulrich
authors.initials: U
authors.lastname: Germing
mesh_terms: D001317:Austria; D015415:Biomarkers; D020732:Cytogenetic Analysis; D019937:Diagnostic Techniques and Procedures; D005434:Flow Cytometry; D005858:Germany; D006801:Humans; D007150:Immunohistochemistry; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000175:diagnosis*; D011379:Prognosis; D013557:Switzerland
chemical_list: D015415:Biomarkers